Reported by China’s National Bureau of Statistics for 2024.
View source
Peptide research.
In one clear catalogue.
NewsTwo secret labs, 80 peptides, €2.5 million: what Slovakia's raids reveal about Europe's peptide grey marketWhy China matters
in biotechnology research.
China has substantial research investment, active medical product innovation and established clinical research infrastructure. These factors make it an important biotechnology research sector.
Reported by China’s NMPA as approved in 2024.
View sourceIdentified in a 2023 analysis of ChiCTR records through October 2020.
View sourcePeptide research
by scientific field.
Swipe or drag through research areas by scientific field. The card in the centre sets the catalogue filter below.

All peptides
View every available research record in the catalogue.

Metabolic
Endocrine signalling and physiological reference research.

Neuroscience
Neurobiology, receptor pharmacology and signalling contexts.

Reproductive & endocrine
Pituitary gonadal signalling and reproductive biology research.

Growth hormone & endocrine
Pituitary and endocrine pharmacology research.

Dermal & formulation
Cosmetic formulation, sensory and material research contexts.

Cardiovascular
Vascular, cardiovascular and hemodynamic biology research.

Gastrointestinal
Peptide biology, secretion and motility research.

Tissue & regenerative
Tissue, cellular, scaffold and regenerative biology research.

Skeletal & mineral
Bone, mineral, osteoblast and endocrine mineral research.

Specialist & translational
Cross disciplinary, imaging and specialist research listings.
All research peptides are listed below.
96 research records in the catalogue
Search guides and news5-Amino-1MQ 5mg
A 5mg small molecule NNMT inhibitor studied in cells and mice. Supplied for research, with no published human clinical trials.
Preclinical Quote availableBacteriostatic Water 10ml
Sterile water containing 0.9% benzyl alcohol, supplied in a 10ml vial for reconstituting lyophilised peptides and other compounds in the laboratory.
Research supply Quote availableBB20 Blend 20mg
A lyophilised blend containing 10mg BPC-157 and 10mg TB-500. The combination itself has not been evaluated in published studies.
Blend not evaluated Quote availableCagrilintide 10mg
A 10mg lyophilised synthetic amylin analogue studied in Phase 3 trials with semaglutide. Supplied in a single vial for research use only.
Late stage Quote availableCJC-1295 Without DAC / MOD GRF 1–29
The best known human pharmacology study assessed DAC CJC-1295 in healthy adults.
Early human Quote availableElamipretide
A mitochondria targeting tetrapeptide with accelerated FDA approval for a defined Barth syndrome strength endpoint; broader mitochondrial myopathy and heart failure programmes remain investigational or have not met key endpoints.
Quote availableEloralintide
An investigational weekly amylin receptor agonist with Phase 1/2 weight management findings and a Phase 3 programme spanning obesity, type 2 diabetes, sleep apnoea and knee osteoarthritis.
Late stage Quote availableGlow GHK-CU Blend
Copper peptide evidence is mainly mechanistic, cell, animal, topical and cosmetic, and review level.
Quote availableIRGD
Research includes cell systems, spheroids, nanoparticles, imaging constructs, animal cancer models, and early human studies of related development compounds.
Early human Quote availableKLOW Blend 80mg
An 80mg lyophilised four peptide blend for tissue repair and inflammation research. The combination has not been evaluated in published studies.
Blend not evaluated Quote availableMazdutide 5mg
A 5mg lyophilised oxyntomodulin analogue acting on GLP-1 and glucagon receptors. Supplied for research, not as a licensed medicine.
Quote availableMOTS-c 40mg
A 40mg lyophilised mitochondrial peptide studied mainly in mice and cell models for metabolism, insulin sensitivity and exercise capacity.
Preclinical Quote availableOligopeptide P11-4
A self assembling peptide studied in professional topical dental formulations for early, non cavitated caries; randomised evidence concerns lesion size and caries inactivation outcomes, not established cavities or generic peptide material.
Early human Quote availablePalmitoyl Pentapeptide-4 / Palmitoyl Pentapeptide-3
A 2005 double blind split face moisturizer study and a 2023 21 participant randomized topical study reported exploratory cosmetic signals.
Early human Quote availablePT-141 10mg
A 10mg lyophilised synthetic cyclic heptapeptide activating melanocortin receptors, mainly MC4R. Supplied for research, not as a licensed medicine.
Quote availableRetatrutide
An investigational triple hormone receptor agonist in Phase 3 trials spanning obesity, type 2 diabetes and obesity related conditions including sleep apnoea and knee osteoarthritis.
Late stage Quote availableSemaglutide
A GLP-1 receptor agonist supported by major randomised programmes in type 2 diabetes, chronic weight management and cardiovascular outcomes; authorisation depends on the named finished product, formulation, dose and indication.
Quote availableSermorelin
Research concerns GH stimulation testing and historical pediatric growth failure treatment.
Late stage Quote availableTB-500 10mg
A 10mg lyophilised synthetic peptide corresponding to a region of thymosin beta 4. Studied in cell and animal models, with no human trials for this peptide.
Preclinical Quote availableTesamorelin
A GHRH analogue with randomised evidence of reduced visceral abdominal fat in adults with HIV associated lipodystrophy; defined finished products are authorised for that specific context, not general weight loss.
Quote availableThymosin Alpha-1 5mg
A 5mg lyophilised 28 amino acid peptide studied in immune response regulation, particularly T cell function. Supplied for research, not as a licensed medicine.
Quote availableTirzepatide 50mg
A 50mg lyophilised synthetic peptide acting on GIP and glucagon like peptide 1 receptors. Supplied in a single vial for research, not as a licensed medicine.
Quote available(5-Leucine)Enkephalin
Research concerns opioid physiology, pain, stress, receptor pharmacology, analytical standards, animal models, and modified analogues/prodrugs.
PreclinicalAbaloparatide
A parathyroid hormone related peptide analogue with Phase 3 osteoporosis evidence for fewer new vertebral and nonvertebral fractures and increased bone mineral density in postmenopausal women.
Acetyl Tetrapeptide-15
A review reports supplier sponsored sensory neuron experiments and a 20 participant split face, single blind topical study using a capsaicin discomfort endpoint.
Early humanAlarelin
Research spans animal reproductive biology, veterinary applications, and limited human investigation.
Early humanAmunine
Direct evidence is older endocrine physiology and biochemical purification work, including 1982 pituitary cell and dog studies.
PreclinicalAntide / Vapreotide Acetate
Vapreotide has historical research in variceal bleeding and other gastrointestinal/endocrine contexts; Antide research is separate and mainly preclinical.
Early humanARA-290 / Cibinetide
An investigational erythropoietin derived peptide with small early phase studies in sarcoidosis associated small fiber neuropathy, diabetic macular oedema and metabolic contexts; no authorised indication has been identified.
Early humanArg(34)GLP-1 (7–37)
The unacylated item mainly appears as a research intermediate, comparator, or building block in GLP-1 analogue design.
PreclinicalAviptadil
Human research includes an exploratory 20 participant pulmonary hypertension study and COVID-19 respiratory failure trials.
Early humanBeta-Endorphin
Research examines pain, stress/reward, neuroendocrine signaling, and associations with neurological/psychiatric conditions.
Early humanBeta-Neoendorphin
It is principally a biochemical and preclinical research model.
PreclinicalBPC-157
Research is dominated by animal and laboratory soft tissue, gastrointestinal, tendon, ligament, and muscle injury models.
PreclinicalBuserelin
Historical human research spans IVF protocols, endometriosis, hormone sensitive oncology, and pediatric endocrinology.
Early humanC-Peptide
Human use is mainly measurement for diabetes classification, endogenous insulin assessment, and beta cell function trials.
Late stageCarbetocin Acetate
Research mainly concerns prevention of postpartum haemorrhage.
Carperitide
Human research is concentrated in acute heart failure in Japan.
CBL-514
An investigational small molecule injection studied in early Phase II/IIa programmes for localized abdominal subcutaneous fat and cellulite; it is not an authorised medicine and other development areas remain exploratory.
Early humanCilengitide
It was developed as an investigational anticancer agent, principally in glioblastoma.
Late stageDermorphin
Evidence is principally preclinical pharmacology and rodent analgesia.
PreclinicalDeslorelin
The clearest documented context is veterinary reproductive endocrine research and controlled release implants, with limited human endocrine research.
Desmopressin Acetate
Research includes peptide delivery and stability studies and established clinical pharmacology in central diabetes insipidus and selected hemostasis related conditions.
Dipeptide-2
Located literature is chemical, computational, or supplier generated.
PreclinicalDynorphin A (1–17)
Research concerns opioid signaling, pain and stress biology, neuroinflammation, addiction related processes, and inflammatory/cardiovascular models.
PreclinicalEdotreotide
The authorized clinical context is gallium 68 radiolabelling for PET imaging of somatostatin receptor positive gastroenteropancreatic neuroendocrine tumours.
Enfuvirtide
It was developed for treatment experienced HIV-1 infection; TORO studies found improved short term virologic response when added to optimized background therapy, with resistance associated gp41 substitutions documented.
Epithalon
Evidence is predominantly cell, animal, and in silico research.
PreclinicalEptifibatide
Large acute coronary syndrome and PCI research includes PURSUIT, in which eptifibatide reduced the 30 day composite of death or nonfatal MI but increased bleeding.
Etelcalcetide
Its primary clinical context is secondary hyperparathyroidism in adults with chronic kidney disease on hemodialysis.
Exenatide Acetate
Extensive human research in type 2 diabetes includes randomized studies and extensions of defined drug products.
Felypressin Acetate
Research largely concerns felypressin as the vasoconstrictor component of prilocaine with felypressin local anesthetic products, especially dental or cervical procedures.
Ganirelix Acetate
Controlled ovarian stimulation studies evaluated ganirelix for prevention of premature LH surges.
GHRP-2
Human research has largely examined acute endocrine pharmacology, GH stimulation/testing, pharmacokinetics, and appetite biology.
PreclinicalGHRP-6
Research is mainly experimental endocrine pharmacology, receptor biology, pharmacokinetics, and preclinical tissue protection work.
Early humanGLP-1 (7–37)
It is primarily a native peptide research tool and physiologic reference.
PreclinicalGonadorelin Acetate
Human research and historical clinical use include endocrine stimulation testing, reproductive endocrinology, and pulsatile treatment of selected hypothalamic GnRH deficiency states.
Goserelin
It is a clinical pharmacology and hormone dependent disease research agent.
Hexapeptide-3
Human evidence located consists of small finished formulation studies, including a 24 participant 60 day study of acetyl hexapeptide 3 containing formulations.
Early humanHexarelin
Research predominantly examines short term GH and pituitary responses.
Early humanHGH Fragment 177–191
Evidence is largely rodent, isolated adipose tissue, and mechanistic research concerning lipid metabolism.
PreclinicalHistrelin Acetate
FDA labeling and registered studies support long acting subcutaneous histrelin implants for central precocious puberty and advanced prostate cancer contexts.
Icatibant Acetate
The strongest research is acute hereditary angioedema (HAE).
Ipamorelin
Research includes pituitary cell, rat, and swine pharmacology and a registered human postoperative gastrointestinal function study.
Early humanLanreotide
Clinical research includes acromegaly, carcinoid syndrome, and somatostatin receptor positive enteropancreatic neuroendocrine tumors.
Larazotide Acetate
The main human research context is celiac disease.
Late stageLeuprorelin Acetate / Leuprolide Acetate
It has extensive clinical and regulatory history in advanced prostate cancer and, depending on formulation and jurisdiction, endometriosis, fibroids, and central precocious puberty.
Linaclotide
A guanylate cyclase C agonist with a defined GC-C/cGMP mechanism and randomised trial evidence in specified constipation related disorders; authorised uses depend on the finished product, population and jurisdiction.
Lixisenatide
Clinical research is primarily in type 2 diabetes.
Lixisenatide Acetate
It has phase III human research in type 2 diabetes, including add on studies with basal insulin and metformin.
LL-37
An investigational human cathelicidin studied in topical venous leg ulcer trials and exploratory biomarker work; its broad antimicrobial, immune, regenerative and oncology research remains largely preclinical.
Early humanMelanotan-II / MT2
Human evidence is very small and early: a three participant phase I pilot reported pigmentation and adverse effects, and a 20 participant erectile dysfunction study reported responses with frequent nausea/yawning.
Early humanMOG (35–55)
It is an experimental antigen used to induce or study experimental autoimmune encephalomyelitis in susceptible rodents.
PreclinicalNAD+
Nicotinamide adenine dinucleotide is a cellular coenzyme studied in redox reactions, energy metabolism and signalling. It is a small molecule cofactor rather than a peptide.
PreclinicalNafarelin
Research spans endometriosis, central precocious puberty, assisted reproduction, fibroids, and other pituitary gonadal axis contexts.
Octreotide Acetate
It has extensive clinical research in acromegaly, secretory syndromes of certain neuroendocrine tumors, and gastroenteropancreatic neuroendocrine tumour research.
OGP
Osteogenic growth peptide research concerns bone, osteoblast, fracture healing, and hematopoietic models.
PreclinicalOpiorphin
Research is biochemical, ex vivo, and rodent analgesia work.
PreclinicalPalmitoyl Tetrapeptide-7/3
Research is cosmetic/cosmeceutical, including cell assays, patents, and formulation testing.
PreclinicalPasireotide
It has phase II/III research in Cushing’s disease and acromegaly and distinct investigations in neuroendocrine tumors and perioperative pancreatic settings.
PE 22–28 Acetate
Research comprises recombinant channel assays, neuronal studies, and mouse behavioral/neurogenesis experiments.
PreclinicalPramlintide Acetate
It has extensive human diabetes research as adjunct to insulin in type 1 and type 2 diabetes, with gastrointestinal adverse effects and clinically important hypoglycemia risk in the treatment setting.
Secretin Acetate
The strongest human context is diagnostic stimulation of pancreatic secretion and gastrin release.
Selank
Small comparative Russian studies in anxiety/neurasthenia and phobic anxiety and somatoform disorders have been published, alongside animal, receptor, and gene expression work.
Early humanSemax Acetate
Research focuses on neuroprotection, stroke recovery, neurotrophin related signaling, and brain network effects.
Early humanSincalide
Human research uses sincalide as a controlled physiologic/diagnostic stimulus, including cholescintigraphy measurement standardization.
Somatostatin Acetate
It is a mechanistic research reagent for endocrine regulation, gastrointestinal secretion/motility, metabolism, and receptor biology.
Late stageTeriparatide Acetate
A PTH(1–34) analogue with strong randomised evidence for reduced vertebral and nonvertebral fractures in specified high risk osteoporosis populations; authorisation applies to defined finished products, not a generic catalogue material.
Terlipressin Acetate
Clinical research principally concerns hepatorenal syndrome with rapidly declining kidney function in advanced cirrhosis and related portal/hemodynamic contexts.
Tetracosactide Acetate
Its established context is regulated adrenal reserve diagnostic stimulation.
Thymosin Beta-4
Research includes cell and animal injury models and early human studies.
Early humanThymosin β4 (1–4)
A short thymosin beta 4 fragment listed in tissue biology research. Evidence for full length thymosin beta 4 should be distinguished from evidence for this four residue fragment.
PreclinicalTripeptide-1 / Copper Peptide
Copper binding tripeptide research examines extracellular matrix signalling, fibroblast responses and topical formulation properties. The free peptide and copper complex have distinct identities.
PreclinicalTriptorelin Acetate
Human research spans pituitary gonadal axis suppression, central precocious puberty, fertility protocols, and oncology.
Vapreotide Acetate
The principal clinical research context was acute portal hypertension related oesophageal variceal bleeding.
Late stageZiconotide
It was developed as a non opioid analgesic with clinical trials in severe chronic pain.
Evidence levels describe published research on the molecule or a defined reference product. They are separate from the specification and status of the catalogue material.
What each record
should include.
A useful batch record connects the molecule, supplier and analytical results. Our guides explain how to check product identity, purity, test methods and supporting documents.
Research information
clearly explained.
These guides explain product records, supporting documents and public research evidence.
How to read a peptide COA
A practical guide to identity, purity, method scope and batch-specific interpretation.
Read the guideHow to read peptide clinical research
A practical guide to study questions, evidence levels, endpoints and research limitations.
Read the guideOrientSciences traceability guide
How source, batch, test, document and product record should connect.
Read the guideLongevity & peptide research
An educational overview of evidence levels, mechanisms, limitations and common research questions.
Explore researchPeptide questions & answers
Clear research-focused answers on identity, evidence, clinical records and analytical documentation.
Read the answersPeptide news from
around the world.
Daily reports on peptide and biotech research from around the world, with clear publication dates and links to the trials and studies behind each story.
Two secret labs, 80 peptides, €2.5 million: what Slovakia's raids reveal about Europe's peptide grey market
Slovak police seized over 80 types of peptides and two equipped labs, with Interpol and WADA. What it says about Europe's peptide grey market.
Read the articleIs China's rival to tirzepatide now ahead of Lilly? What the ribupatide trial shows
China's own GIP/GLP-1 drug, not a copy of tirzepatide, cut weight 17.7% in 48 weeks, level with tirzepatide's 17.5% in China. What the JAMA paper shows.
Read the articleSemaglutide in children under 12: what the full STEP Young paper shows, and what it leaves open
Full STEP Young data in the NEJM: BMI fell 13.5% in children aged 6 to under 12 on semaglutide. What the paper shows, and what its public abstract leaves open.
Read the article